With the availability of tailored recombinant proteins and the opportunity to produce high amounts of monoclonal antibodies new diagnostic applications have emerged and many therapeutic perspectives eg in the treatment of multiple sclerosis and of cancer are being discussed today. Biotechnology can create recombinant vaccines based on viral genes these new modes of treatment give drug developers more options in determining the best way to counteract a disease but biotechnology research and development rd like pharmaceutical rd is a long and demanding process with many hurdles that must be cleared to achieve success. The sciences behind the rise of biotechnology monoclonal antibodies this makes them a good delivery tool for inserting foreign genes into organism a process that is critical to producing recombinant dna and multiplying genes of interest they are also used to develop dna vaccines. Get this from a library biotechnology vol 5a recombinant proteins monoclonal antibodies and therapeutic genes hans jurgen rehm gerald reed a mountain u ney d schomburg. Therapeutic antibodies are a key driving force in the biotechnology industry thanks to their ability to safely and effectively target a broad range of diseases including cancer autoimmune
How it works:
1. Register a Free 1 month Trial Account.
2. Download as many books as you like ( Personal use )
3. No Commitment. Cancel anytime.
4. Join Over 100.000 Happy Readers.
5. That's it. What you waiting for? Sign Up and Get Your Books.